1. TopBP1 assembles nuclear condensates to switch on ATR signaling.
- Author
-
Frattini C, Promonet A, Alghoul E, Vidal-Eychenie S, Lamarque M, Blanchard MP, Urbach S, Basbous J, and Constantinou A
- Subjects
- Amino Acid Substitution, Animals, Checkpoint Kinase 1 chemistry, Checkpoint Kinase 1 genetics, Checkpoint Kinase 1 metabolism, HeLa Cells, Humans, Sf9 Cells, Spodoptera, Ataxia Telangiectasia Mutated Proteins chemistry, Ataxia Telangiectasia Mutated Proteins genetics, Ataxia Telangiectasia Mutated Proteins metabolism, Carrier Proteins chemistry, Carrier Proteins genetics, Carrier Proteins metabolism, Cell Nucleus chemistry, Cell Nucleus genetics, Cell Nucleus metabolism, DNA-Binding Proteins chemistry, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Mutation, Missense, Nuclear Proteins chemistry, Nuclear Proteins genetics, Nuclear Proteins metabolism, Signal Transduction
- Abstract
ATR checkpoint signaling is crucial for cellular responses to DNA replication impediments. Using an optogenetic platform, we show that TopBP1, the main activator of ATR, self-assembles extensively to yield micrometer-sized condensates. These opto-TopBP1 condensates are functional entities organized in tightly packed clusters of spherical nano-particles. TopBP1 condensates are reversible, occasionally fuse, and co-localize with TopBP1 partner proteins. We provide evidence that TopBP1 condensation is a molecular switch that amplifies ATR activity to phosphorylate checkpoint kinase 1 (Chk1) and slow down replication forks. Single amino acid substitutions of key residues in the intrinsically disordered ATR activation domain disrupt TopBP1 condensation and consequently ATR/Chk1 signaling. In physiologic salt concentration and pH, purified TopBP1 undergoes liquid-liquid phase separation in vitro. We propose that the actuation mechanism of ATR signaling is the assembly of TopBP1 condensates driven by highly regulated multivalent and cooperative interactions., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF